Adults 18-70 years of age, with diagnosis of ulcerative colitis are needed for a research study. This study is funded by the NIH.

The Merit-UC study is looking at whether Methotrexate is safe and effective in people with ulcerative colitis that is not well controlled using their current medication. Qualified participants will receive study-related medication and health assessments at no cost.

Compensation provided.

If interested, please contact Guillermina Cruz (713) 798-8220 or Janette Gonzalez (713) 798-7616.

For more information, see Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (Merit-UC).

This research is sponsored by Baylor College of Medicine.